Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
August 9, 2022
Patent Application Number
16542642
Date Filed
August 16, 2019
Patent Citations
Patent Primary Examiner
Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.